Delisting risk
PULM · NASDAQ · Biotechnology

Pulmatrix (PULM)

Dry-powder inhalation technology and clinical assets awaiting licensing or monetization.

$1.47
At close−0.05 (−3.61%)

Something off on this page? Send us feedback.

Next report
Nov 5, 2026
estimated · in 63 days
EPS estimate
−$2.00
Revenue estimate
$1.5M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Oct '25Feb '26May '26Aug '26Nov '26
Reported−$0.54−$0.50−$0.42−$0.24−$0.25−$0.32−$0.29Pending
Estimate−$2.00−$2.00
Surprise+85.5%

RevenueReportedEstimate

Mar '25May '25Aug '25Oct '25Feb '26May '26Aug '26Nov '26
Reported$3.0KPending
Estimate$1.5M
Surprise

History

DateEstimateReportedSurprise
Nov 2026−$2.00
Aug 2026−$2.00−$0.29+85.5%
May 2026−$0.32
Feb 2026−$0.25
Oct 2025−$0.24

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Mar 2020
Nov 2019
Aug 2019
May 2019
Feb 2019
Nov 2018
Aug 2018
May 2018
Mar 2018
Nov 2017
Aug 2017
May 2017
Mar 2017
Nov 2016
Aug 2016
May 2016
Mar 2016
Nov 2015
Aug 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Nov 5, 2026−$2.00$1.5M
Aug 13, 2026−$2.00−$0.29+85.5%−5.6%
May 15, 2026−$0.32+0.8%
Feb 26, 2026−$0.25+2.8%
Oct 16, 2025−$0.24+3.7%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Aug 6, 2025
May 15, 2025
Mar 21, 2025
Nov 8, 2024
Aug 13, 2024
May 10, 2024
Mar 28, 2024
Nov 9, 2023
Aug 10, 2023
May 12, 2023
Mar 30, 2023
Nov 10, 2022
Aug 8, 2022
May 12, 2022
Mar 29, 2022
Nov 10, 2021
Aug 10, 2021
May 11, 2021
Mar 23, 2021
Nov 12, 2020
Aug 7, 2020
May 14, 2020
Mar 26, 2020
Nov 1, 2019
Aug 5, 2019
May 15, 2019
Feb 19, 2019
Nov 14, 2018
Aug 3, 2018
May 11, 2018
Mar 13, 2018
Nov 9, 2017
Aug 4, 2017
May 5, 2017
Mar 10, 2017
Nov 4, 2016
Aug 4, 2016
May 5, 2016
Mar 10, 2016
Nov 12, 2015
Aug 14, 2015